CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 120 enrolled
Drug / intervention
FANMI - Cohort Carebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03286504
NCT03286504N/ACompleted
CompareCT.gov

FANMI: Community Cohort Care for HIV-Infected Adolescent Girls in Haiti

Weill Medical College of Cornell University·interventional·Posted Sep 18, 2017·Updated Nov 7, 2023

In Brief

A clinical study evaluating FANMI - Cohort Care for HIV. Completed, enrolled 120 participants across 1 site.

Detailed Summary

The investigators will conduct a randomized controlled trial of Group Care in the GHESKIO Community Center versus Individual Care in the GHESKIO Adolescent Clinic for 160 HIV-infected adolescent girls age 16-23 years in Haiti (80 adolescents per arm). Group Care includes receiving integrated clinical and social support services in groups of 5-8 adolescents at a monthly visit. The primary outcome is retention in HIV care at 12 months after randomization.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV
CountriesHaiti
CollaboratorsHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 18, 2017
Enrollment StartMay 25, 2018
Primary CompletionJun 1, 2022
Study CompletionOct 1, 2023
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 8.8 years ago

Interventions

FANMI - Cohort Carebehavioral

FANMI includes receiving integrated clinical care, group counseling, and social activities in a single session by the same provider to simplify care and strengthen relationships between peers and providers. FANMI groups consist of 5-10 adolescents meeting once per month.